Tumor necrosis factor-α receptor II polymorphism in patients from Southern Europe with mild-moderate and severe rheumatoid arthritis

Journal of Rheumatology

Volumn 29, Issue 9, 2002, Pages 1847-1850

  Fabris, Martina ^a   Tolusso, Barbara ^a   Di Poi, Emma ^a   Assaloni, Roberta ^a   Sinigaglia, Luigi ^a   Ferraccioli, Gianfranco ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Rheumatoid arthritis; Tumor necrosis factor ; Tumor necrosis factor receptor II polymorphism

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOSPORIN A; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISONE; RECEPTOR SUBTYPE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SYNOVITIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; ITALY; MALE; METHOTREXATE; MIDDLE AGED; ODDS RATIO; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PREDNISONE; PROBABILITY; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 0036733749     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Genetic risk factors for autoimmune diseases
2. The familial nature of rheumatoid arthritis
3. Epidemiology of rheumatoid arthritis: Update
4. Twin concordance rates for rheumatoid arthritis: Results from a nationwide study
5. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
6. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins
7. New susceptibility locus for rheumatoid arthritis suggested by genome-wide linkage study
8. A genomewide screen in multiple rheumatoid arthritis families suggests a genetic overlap with other autoimmune diseases
9. Polymorphic analysis of the high affinity tumor necrosis factor receptor 2
10. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterisation
11. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians
12. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
13. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
14. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis - The methotrexate-cyclosporine combination study group
15. Infliximab and methotrexate in the treatment of RA
16. TNF-α gene polymorphism in severe and mild-moderate rheumatoid arthritis
17. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus
18. Development and validation of the European League Against Rheumatism response criteria in rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria